Ignite Creation Date:
2024-05-06 @ 7:21 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05983237
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-14
First Post:
2023-07-11
Brief Title:
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Sponsor:
Organization:
Peking University Cancer Hospital Institute